2021 Cannabinoids/Marijuana Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

2021 Cannabinoids/Marijuana Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • July 2021 •
  • Report ID: 4775220 •
  • Format: PDF
2021 Cannabinoids/Marijuana Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

This new report provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

The report is available by section, and can be customized to specific information needs and budget.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Market Segmentation

Centralized Testing

- Hospitals
- Commercial/Private Laboratories

POC/Decentralized Testing

- Physician Offices/Group Practices
- Emergency Departments
- Ambulatory Care Centers

List of Tables

France: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Cannabinoids/Marijuana Test Volume and Diagnostics Sales Forecasts by Market Segment